We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Antioxidant Supplements and Cardiovascular Disease in Men

Sebastian J. Padayatty, MD, PhD; Mark Levine, MD
JAMA. 2009;301(13):1335-1337. doi:10.1001/jama.2009.316.
Text Size: A A A
Published online


To the Editor: The conclusion of Dr Sesso and colleagues1 that vitamin C does not affect cardiovascular outcome in male physicians is not surprising because of an experimental design that did not consider human vitamin C physiology and did not include vitamin C measurements. In humans, plasma and tissue vitamin C concentrations are tightly controlled. Plasma concentrations have a steep sigmoidal response in relation to dose, and a similar steep response occurs in tissue.25 At doses above approximately 100 mg daily, circulating immune cells are saturated, and at doses of 200 mg daily or greater, there are only marginal increases in plasma concentrations.25 Physicians in the control group, who likely consumed at least 3 servings of fruits or vegetables daily, would have ingested more than 100 mg of vitamin C per day. Even a single glass of orange juice would have provided 90 mg of vitamin C. Those who took an allowed multivitamin would have had further intake of 60 mg daily. Additional intake of 500 mg daily in the treatment group would not affect tissue concentrations at all and would increase plasma concentrations only marginally.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




April 1, 2009
Francesco Violi, MD; Roberto Cangemi, MD
JAMA. 2009;301(13):1335-1337. doi:10.1001/jama.2009.314.
April 1, 2009
John Martin Evans, MBBCh
JAMA. 2009;301(13):1335-1337. doi:10.1001/jama.2009.315.
April 1, 2009
Howard D. Sesso, ScD, MPH; J. Michael Gaziano, MD, MPH
JAMA. 2009;301(13):1335-1337. doi:10.1001/jama.2009.317.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.